Business

U.S. Employers Add 275,000 Jobs in Another Strong Month

Economists are trying to gauge whether forecasts of a slowing labor market were mistaken or just premature. For now, gains are consistent and strong.Economists are trying to gauge whether forecasts of a slowing labor market were mistaken or just premature. For now, gains are consistent and strong. Labor and Jobs, United States Economy, Hiring and Promotion, […]

U.S. Employers Add 275,000 Jobs in Another Strong Month Read More »

New York-Style Bagels Are Making It Big in London

Bakeries selling big, doughy bagels have opened to rave reviews in Britain, but some traditionalists are standing by the London “beigel.”Bakeries selling big, doughy bagels have opened to rave reviews in Britain, but some traditionalists are standing by the London “beigel.” Bagels, Bakeries and Baked Products, Bread, London (England), United States, New York City Read More

New York-Style Bagels Are Making It Big in London Read More »

What History and Economics Suggest About Biden-Trump, Round 2

Underlying economic and market factors mattered in previous presidential rematches. They may help President Biden, even if polls aren’t showing that so far.Underlying economic and market factors mattered in previous presidential rematches. They may help President Biden, even if polls aren’t showing that so far. Presidential Election of 2024, United States Politics and Government, Presidents and

What History and Economics Suggest About Biden-Trump, Round 2 Read More »

A.L.S. Drug Relyvrio Fails Clinical Trial and May Be Withdrawn From the Market

Leaders of the treatment’s manufacturer, Amylyx, said they would announce their plans for it within eight weeks.Leaders of the treatment’s manufacturer, Amylyx, said they would announce their plans for it within eight weeks. Clinical Trials, Amyotrophic Lateral Sclerosis, Drugs (Pharmaceuticals), Amylyx Pharmaceuticals Inc, Food and Drug Administration, Cohen, Joshua B, Klee, Justin, United States, your-feed-healthcare Read More

A.L.S. Drug Relyvrio Fails Clinical Trial and May Be Withdrawn From the Market Read More »

Dozens of Top Scientists Sign Effort to Prevent A.I. Bioweapons

An agreement by more than 90 said, however, that artificial intelligence’s benefit to the field of biology would exceed any potential harm.An agreement by more than 90 said, however, that artificial intelligence’s benefit to the field of biology would exceed any potential harm. Artificial Intelligence, Biology and Biochemistry, Computers and the Internet, Biological and Chemical Warfare,

Dozens of Top Scientists Sign Effort to Prevent A.I. Bioweapons Read More »

Car Deals Are Easier to Find but Lenders Are Tightening Their Terms

It has become harder for some borrowers to get affordable car loans as banks and dealerships face a rising number of delinquencies.It has become harder for some borrowers to get affordable car loans as banks and dealerships face a rising number of delinquencies. Banking and Financial Institutions, Automobiles, Credit and Debt, Automobile Financing, Credit Scores, Prices

Car Deals Are Easier to Find but Lenders Are Tightening Their Terms Read More »

F.D.A. Delays Action on Closely Watched Alzheimer’s Drug

Eli Lilly’s donanemab was expected to be approved this month, but the agency has decided to convene a panel of independent experts to evaluate the drug’s safety and efficacy.Eli Lilly’s donanemab was expected to be approved this month, but the agency has decided to convene a panel of independent experts to evaluate the drug’s safety

F.D.A. Delays Action on Closely Watched Alzheimer’s Drug Read More »

Biden Portrays Next Phase of Economic Agenda as Middle-Class Lifeline

The president used his State of the Union speech to pitch tax increases for the rich, along with plans to cut costs and protect consumers.The president used his State of the Union speech to pitch tax increases for the rich, along with plans to cut costs and protect consumers. United States Politics and Government, United States

Biden Portrays Next Phase of Economic Agenda as Middle-Class Lifeline Read More »